Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

BACKGROUND: Clinical trials demonstrated that women treated for breast cancer with anthracycline or trastuzumab are at increased risk for heart failure and/or cardiomyopathy (HF/CM), but the generalizability of these findings is unknown. We estimated real-world adjuvant anthracycline and trastuzumab...

詳細記述

保存先:
書誌詳細
主要な著者: Bowles, Erin J. Aiello, Wellman, Robert, Feigelson, Heather Spencer, Onitilo, Adedayo A., Freedman, Andrew N., Delate, Thomas, Allen, Larry A., Nekhlyudov, Larissa, Goddard, Katrina A. B., Davis, Robert L., Habel, Laurel A., Yood, Marianne Ulcickas, Mccarty, Catherine, Magid, David J., Wagner, Edward H., Pharmacovigilance Study Team
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2012
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433392/
https://ncbi.nlm.nih.gov/pubmed/22949432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs317
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料